Stanley-Laman Group’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,573
Closed -$1.35M 262
2020
Q4
$1.35M Buy
10,573
+560
+6% +$63.1K 0.24% 128
2020
Q3
$980K Buy
10,013
+701
+8% +$70.5K 0.22% 131
2020
Q2
$934K Buy
9,312
+14
+0.2% +$1.31K 0.22% 126
2020
Q1
$794K Sell
9,298
-1,204
-11% -$119K 0.24% 120
2019
Q4
$1.22M Buy
10,502
+670
+7% +$73.5K 0.29% 106
2019
Q3
$1.09M Buy
9,832
+4
+0% +$433 0.27% 116
2019
Q2
$1.02M Buy
9,828
+400
+4% +$38.6K 0.24% 130
2019
Q1
$762K Buy
9,428
+35
+0.4% +$2.91K 0.19% 186
2018
Q4
$740K Buy
+9,393
New +$781K 0.21% 179
2016
Q1
Sell
-15,134
Closed -$735K 343
2015
Q4
$735K Buy
+15,134
New +$748K 0.13% 187
2015
Q3
Sell
-94,121
Closed -$5.08M 355
2015
Q2
$5.08M Buy
94,121
+532
+0.6% +$28.4K 0.93% 28
2015
Q1
$4.75M Buy
93,589
+81,605
+681% +$3.96M 0.87% 34
2014
Q4
$571K Buy
+11,984
New +$529K 0.11% 197

Other funds holding SLAB

Stanley-Laman Group's SLAB Position: Q1 2021 in Review

Stanley-Laman Group sold out of Silicon Laboratories (SLAB) in Q1 2021, closing a stake of 10,573 shares — an estimated $1.35M sold.

Stanley-Laman Group first reported a position in SLAB in Q4 2014 and held it in 13 quarters. The position peaked at $5.08M in Q2 2015. 278 funds tracked by Wall St. Rank hold SLAB as of Q1 2021.

  • Stanley-Laman Group reported no remaining Silicon Laboratories position as of Q1 2021 after selling out during the quarter.
  • Stanley-Laman Group sold 10,573 Silicon Laboratories shares in Q1 2021, an estimated $1.35M.
  • Stanley-Laman Group first reported a position in Silicon Laboratories in Q4 2014 and held it in 13 quarters.
  • Stanley-Laman Group's Silicon Laboratories position peaked at $5.08M in Q2 2015.
  • 278 funds tracked by Wall St. Rank held Silicon Laboratories as of Q1 2021.

Based on Stanley-Laman Group's 13F filing for Q1 2021, filed 5 May 2021.